Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APGE

Apogee Therapeutics Inc

Jun 08 • 04:00PM ET

83.01

-3.91 -4.50 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: KYMR BMRN MDGL RYTM VKTX KRYS NUVL AXSM INCY NBIX

| Held by: VTI XBI IWM TCAF VXF IBB IWO SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.33	Insider Own	24.45%	Shs Outstand	61.40M	Perf Week	4.68%
Market Cap	6.26B	Forward P/E	-	EPS next Y	-5.35	Insider Trans	-9.51%	Shs Float	56.96M	Perf Month	1.47%
Enterprise Value	5.21B	PEG	-	EPS next Q	-1.07	Inst Own	92.69%	Short Float	16.45%	Perf Quarter	10.77%
Income	-274.62M	P/S	-	EPS this Y	-3.85%	Inst Trans	17.06%	Short Ratio	9.78	Perf Half Y	9.95%
Sales	0.00M	P/B	4.95	EPS next Y	-22.10%	ROA	-27.35%	Short Interest	9.37M	Perf YTD	9.98%
Book/sh	16.77	P/C	5.90	EPS next 5Y	-12.70%	ROE	-28.47%	52W High	95.32 -12.91%	Perf Year	102.56%
Cash/sh	14.06	P/FCF	-	EPS past 3/5Y	-75.11% -	ROIC	-21.78%	52W Low	34.34 141.73%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.35% 6.03%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-22.17%	Oper. Margin	-	ATR (14)	4.88	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	32.59	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.41	Recom	1.42
Dividend Gr. 3/5Y	- -	Current Ratio	32.59	EPS Q/Q	-11.87%	SMA20	1.10%	Beta	0.64	Target Price	119.24
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-1.22%	Rel Volume	1.38	Prev Close	86.92
Employees	261	LT Debt/Eq	0.00	Earnings	May 11 BMO	SMA200	23.18%	Avg Volume	958.01K	Price	83.01
IPO	Jul 14, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.53% -	Trades		Volume	1,317,009	Change	-4.50%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)